March 2025 Br J Cardiol 2025;32:7–11 doi:10.5837/bjc.2025.011
Muhammad Anis Haider, Muhammad Usman Shah, Xenophon Kassianides, Adil Hazara, Noman Ali, Dmitriy N Feldman
Introduction Acute myocardial infarctions (AMI) occur with an increased frequency in patients receiving long-term dialysis treatment for end-stage renal disease (ESRD). Moreover, these patients have additional comorbidities, such as diabetes mellitus and systemic arterial hypertension, further predisposing individuals to the development of coronary artery disease.1,2 By its very nature, haemodialysis (HD) therapy may be highly disruptive to patients’ lifestyles, as those receiving regular sessions are less likely to perform regular exercise, adhere to a healthy diet, face difficulties complying with medications or adopt health-seeking behav
March 2025 Br J Cardiol 2025;32:3–5 doi:10.5837/bjc.2025.012
Jemima Scott
Cardiovascular disease is the primary cause of premature mortality and morbidity in people with CKD.9,10 The risk of cardiovascular disease increases as kidney function declines, but also notably with an increase in proteinuria;11 those with kidney failure (the relatively new term proposed by the Kidney Disease Improving Global Outcomes [KDIGO] group to encompass all individuals with an estimated glomerular filtration rate [eGFR] <15 ml/min/1.73 m2) experience the greatest risk. It is this association between kidney and cardiac disease that explains the high prevalence of CKD among individuals hospitalised with ACS; the population prevalen
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits